Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Solana Beach, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Evoke Pharma Inc has filed 665 SEC EDGAR filings since 11 Jun 2007

SEC filing history

Showing 251-275 of 662 matching filings.

Per page
25
Current page
11
8-K File 001-36075

8-K

Filing date
12 Aug 2021
Reporting date
12 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jul 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jul 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jul 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jul 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jul 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
14 Jul 2021
Reporting date
14 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
29 Jun 2021
Reporting date
29 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
15 Jun 2021
Reporting date
15 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - PATENT-ORANGE BOOK APPROVAL

Filing date
08 Jun 2021
Reporting date
08 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - PATENT-ORANGE BOOK

Filing date
02 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - REED APPOINTMENT

Filing date
14 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - Q12021

Filing date
12 May 2021
Reporting date
12 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87872

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
06 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - 2021 ANNUAL MEETING

Filing date
06 May 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K - USPTO ORANGE BOOK

Filing date
06 Apr 2021
Reporting date
06 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36075

DEFA14A

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36075

DEF 14A

Filing date
26 Mar 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87872

AMENDMENT TO SC 13G

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
23 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36075

PRE 14A

Filing date
12 Mar 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .